Centre Hospitalier de l'Université de Montréal/Montreal Hospital University Center (CHUM)

Montreal, Quebec H2X 0A9

0 studies enrolling now · 1 studies all time

What they study most

HER2 Positive Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer

Studies at this site

• TAC T-cells for the Treatment of HER2-positive Solid Tumors — Stopped early